As illustrated in Figure 4D–F, the longitudinal follow‐up of checkpoint levels per patient showed a strong and similar downregulation of sPD‐L1, sTIM‐3, and sGAL‐9 1 year post‐COVID‐19. The gene discussed is SPDL1; the disease is COVID-19.